GlassScriptPhysician profile
Andrew D Pearle
NPI 1427071778
$6,657,479.98
in general payments reported to CMS, 2019-2025
10 companies · $201K in 2025
The $201K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119K · 2020: $7,250 · 2021: $37K · 2022: $5.8M · 2023: $486K · 2024: $15K · 2025: $201K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $665K · Consulting Fee: $31K · Travel and Lodging: $4,124 · Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $665,067.55 |
| Consulting Fee | $30,942.50 |
| Travel and Lodging | $4,124.37 |
| Food and Beverage | $1,115.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,497,423.31 | 2019-2025 | Engage Partial Knee System, Journey II, Real Intelligence |
| Zimmer Biomet Holdings, INC. | $61,002.77 | 2019-2024 | Juggerknotless Soft Anchor |
| Exactech, INC. | $44,964.22 | 2019 | |
| Depuy Synthes Products, INC. | $36,360.78 | 2021-2024 | Attune, Depuy Synthes Advantage, Velys |
| Stryker Corporation | $14,764.75 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,652.30 | 2021-2022 | |
| Globus Medical, INC. | $763.05 | 2024-2025 | Actify 3d, Actify |
| Engage Uni, LLC | $348.84 | 2020-2021 | |
| Orthosensor INC. | $125.01 | 2019 | |
| Arthrex, INC. | $74.95 | 2023 | Arthrex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,487,537.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pearle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.